Status:
COMPLETED
Side Effects After Direct-acting Antiviral Treatment
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Chronic Hepatitis c
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study was to assess the incidence of side effects after direct-acting antiviral therapy in patients with chronic hepatitis C virus infection.
Detailed Description
Direct-acting antiviral (DAA)-based treatments are today very effective The objective of this study was to assess the incidence of side effects after DAA therapy in patients with chronic hepatitis C v...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Hepatitis C virus infection
- Treatment by direct-acting antiviral combination
Exclusion
- HIV coinfection
Key Trial Info
Start Date :
May 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2017
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT03346941
Start Date
May 1 2016
End Date
October 31 2017
Last Update
November 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Croix-Rousse Hospital, Hospices Civils de Lyon
Lyon, France, 69004